Cigarette Smoking and Diabetes: An Update

Diabetic Medicine

Volumn 11, Issue 4, 1994, Pages 336-343

  Mühlhauser, Ingrid ^a  

^a HEINRICH HEINE UNIVERSITY   (Germany)

Author keywords

Atherosclerosis; Diabetes; Mortality; Nephropathy; Retinopathy; Smoking

Indexed keywords

ATHEROSCLEROSIS; CIGARETTE SMOKING; DIABETES MELLITUS; DIABETIC NEPHROPATHY; DIABETIC RETINOPATHY; HUMAN; MORTALITY; PATHOGENESIS; REVIEW;

CLINICAL TRIALS; DIABETES MELLITUS; DIABETIC ANGIOPATHIES; DIABETIC NEPHROPATHIES; DIABETIC RETINOPATHY; HUMAN; PROGNOSIS; RISK FACTORS; SMOKING; SUPPORT, NON-U.S. GOV'T;

EID: 0028360601     PISSN: 07423071     EISSN: 14645491     Source Type: Journal    
DOI: 10.1111/j.1464-5491.1994.tb00283.x     Document Type: Review

References (102)

1. Smoking and diabetes
2. Meta‐analysis of effects of intensive blood glucose control on late complications of type 1 diabetes
3. Improved survival in patients with diabetic nephropathy
4. Cigarette smoking and prevalence of microangiopathy in juvenile‐onset insulin‐dependent diabetes mellitus
5. Smoking habits and prevalence of clinical diabetic microangiopathy in insulin‐dependent diabetics
6. Smoking and diabetic nephropathy
7. Cigarette‐smoking as a risk factor for macroproteinuria and proliferative retinopathy in Type 1 (insulin‐dependent) diabetes
8. Tobacco and end stage diabetic nephropathy
9. The natural history of insulin‐dependent diabetes mellitus in Denmark: 1. Long‐term survival with and without late diabetic complications
10. Absence of a relationship between smoking and diabetic microangiopathy
11. Interrelationships of microangiopathy, plasma glucose and other risk factors in 3583 diabetic patients: a multinational study
12. Is cigarette smoking associated with diabetic retinopathy?
13. Proteinuria in diabetes
14. A study of patients with diabetes mellitus (type 1) and end‐stage renal failure: tobacco usage may increase risk of nephropathy and death
15. Cigarette smoking and glomerular filtration rate in insulin‐treated diabetics without manifest nephropathy
16. Cigarette smoking increases the risk of albuminuria among subjects with Type 1 diabetes
17. The determinants of early nephropathy in insulin‐dependent diabetes mellitus: a prospective study based on the urinary excretion of albumin
18. Cigarette smoking and urinary albumin excretion in insulin‐treated diabetics without manifest nephropathy
19. Clinical prognostic factors in lupus nephritis. The importance of hypertension and smoking
20. Incidence of gross proteinuria in older‐onset diabetes. A population‐based perspective
21. Risk factors for development of microalbuminuria in insulin dependent diabetic patients: a cohort study
22. Leucocyte count, proteinuria and smoking in type 1 diabetes mellitus
23. Smoking is associated with progression of diabetic nephropathy
24. Microalbuminuria in a population‐based study of diabetes
25. Prevalence of microalbuminuria in older‐onset diabetes
26. Predictors of microalbuminuria in individuals with IDDM
27. Elevation of ambulatory systolic blood pressure in hypertensive smokers. A case control study
28. Persistent blood pressure increase induced by heavy smoking
29. Elevated urinary excretion of β‐hexosaminidase in smokers
30. Renal effects of cadmium body burden of the general population
31. Urinary excretion of beta‐thromboglobulin and N‐acetyl‐beta‐glucosaminidase in type 1 diabetes: potential indicators of early nephropathy?
32. Increased excretion of urinary N‐acetyl‐β‐glucosaminidase in essential hypertension and its decline with antihypertensive therapy
33. Factors influencing the onset and progression of diabetic retinopathy in subjects with insulin‐dependent diabetes mellitus
34. Cigarette smoking and diabetic retinopathy
35. Smoking and diabetic microangiopathy (Letter)
36. HLA antigens and other risk factors in the development of retinopathy in type 1 diabetes
37. Factors protective against retinopathy in insulin‐dependent diabetics free of retinopathy for 30 years (Letter)
38. Cigarette smoking, blood pressure and the control of blood glucose in the development of diabetic retinopathy
39. Four‐year follow‐up of retinal status and glycosylated haemoglobin in patients with insulin‐dependent diabetes mellitus
40. An epidemiologic approach to the study of retinopathy: the Pittsburgh diabetic morbidity and retinopathy studies
41. Association between retinopathy and impaired peripheral arterial circulation in insulin‐dependent diabetic patients
42. Diabetes in Utah among adults: interaction between diabetes and other risk factors for microvascular and macrovascular complications
43. Influence of smoking on insulin requirement and metabolic status in diabetes mellitus
44. Factors protective against retinopathy in insulin‐dependent diabetics free of retinopathy for 30 years
45. Study of possible risk factors for severe retinopathy in non‐insulin dependent diabetes
46. Prevalence and 15‐year incidence of retinopathy and associated characteristics in middle‐aged and elderly diabetic men
47. Risk factors for diabetic retinopathy: a population based study in Rochester, Minnesota
48. Multiple factors in the prediction of risk of proliferative diabetic retinopathy
49. Association of cigarette smoking with diabetic retinopathy
50. Risk factors for progression of microvascular complications in the Stockholm Diabetes Intervention Study (SDIS)
51. Intensified conventional insulin treatment retards the microvascular complications in insulin dependent diabetes mellitus (IDDM): the Stockholm Diabetes Intervention Study (SDIS) after five years
52. Relation of ocular and systemic factors to survival in diabetes
53. Insulin‐dependent diabetes mellitus mortality. The risk of cigarette smoking
54. Are conventional risk factors for mortality relevant in Type 2 diabetes?
55. Risk factors for coronary heart disease in diabetes mellitus
56. Coronary heart disease in young Type 1 (insulin‐dependent) diabetic patients with and without diabetic nephropathy: incidence and risk factors
57. Intravenous glucose tolerance and mortality in non‐insulin‐dependent diabetes mellitus
58. Interaction between cigarette smoking and diabetes mellitus in the prediction of death attributed to cardiovascular disease
59. Impact of cardiovascular risk factors on coronary heart disease and mortality among middle aged diabetic men: a general population study
60. A prospective study of mortality among middle‐aged diabetic patients (the London cohort of the WHO multinational study of vascular disease in diabetics) II: associated risk factors
61. Microalbuminuria as predictor of increased mortality in elderly people
62. Risk factors for early death in non‐insulin dependent diabetes and men with known glucose tolerance status
63. Risk factors for mortality from all causes and from coronary heart disease among persons with diabetes. Findings from the National Health and Nutrition Examination Survey I. Epidemiological follow‐up study
64. A prospective study of maturity‐onset diabetes mellitus and risk of coronary heart disease and stroke in women
65. Diabetes, other risk fators, and 12‐yr cardiovascular mortality for men screened in the multiple risk factor intervention trial
66. Prevalence of, and risk factors for, angiographically determined coronary artery disease in Type 1 diabetic patients with nephropathy
67. Elevated nicotine levels in patients undergoing hemodialysis. A role in cardiovascular mortality and morbidity?
68. Microalbuminuria. Implications for micro‐ and macrovascular disease
69. How can we best prolong life? Benefits of coronary risk factor reduction in non‐diabetic and diabetic subjects
70. Mortality rates after 10.5 years for participants in the Multiple Risk Factor Intervention Trial
71. The relationship of smoking cessation to coronary heart disease and lung cancer in the Multiple Risk Factor Intervention Trial
72. Comparison of smoking behavior change for SI and UC study groups
73. Cigarette smoking and mortality
74. Association between baseline risk factors, cigarette smoking, and CHD mortality after 10.5 years
75. A randomised controlled trial of anti‐smoking advice: 10‐year results
76. Effect of nicotine chewing gum in combination with group counseling on the cessation of smoking
77. The Oslo Study: diet and antismoking advice
78. Risk factors for macrovascular disease in diabetes mellitus: the London follow‐up to the WHO multinational study of vascular disease in diabetics
79. Progression of peripheral occlusive arterial disease in diabetes mellitus. What factors are predictive?
80. The prevalence and incidence of lower extremity amputation in a diabetic population
81. Qualitätskontrolle der Langzeittherapie über 5 Jahre von älteren, insulinpflichtigen Diabetikern nach einem stationären Diabetes‐Behandlungs‐und‐Schulungsprogramm (Abstract)
82. Lipid and lipoprotein levels in patients with IDDM
83. Cigarette smoking and serum lipid lipoprotein concentrations: an analysis of published data
84. Cigarette smoking, polyunsaturated fats, linoleic acid, and coronary heart disease
85. Relationship between smoking and diet: the MONICA‐France project
86. Smoking and insulin sensitivity in Type 1 diabetic patients
87. Insulin resistance and cigarette smoking
88. Smoking induces insulin resistance—a potential link with the insulin resistance syndrome
89. Effect of cigarette smoking and of a transdermal nicotine delivery system on glucoregulation in type 2 diabetes mellitus
90. Significance of high HbAl levels in normal glucose tolerance
91. Cigarette smoking and the risk of diabetes in women
92. Risk factors for the development of type 2 diabetes among men enrolled in the usual care group of the Multiple Risk Factor Intervention Trial
93. Predictors of glycaemic control in Type 1 diabetic patients after participation in an intensified treatment and teaching programme
94. Failure to prevent nicotine addiction in young people with diabetes
95. Smoking in diabetic teenagers
96. Smoking and metabolic control in patients with insulin‐dependent diabetes mellitus
97. Smoking and glycaemic control in mate insulin dependent (Type 1) diabetics
98. Dropout and relapse during diabetes care
99. Smokers with IDDM experience excess morbidity. The Colorado IDDM registry
100. Anti‐smoking advice for youne diabetic smokers: is it a waste of breath?
101. Anti‐smoking programme for diabetic patients: the agony and the ecstasy
102. Behaviour therapy versus doctor's anti‐smoking advice in diabetic patients